NM_001330588.2:c.496-3T>G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_001330588.2(TPP2):​c.496-3T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

TPP2
NM_001330588.2 splice_region, intron

Scores

2
Splicing: ADA: 0.9731
1
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.562

Publications

0 publications found
Variant links:
Genes affected
TPP2 (HGNC:12016): (tripeptidyl peptidase 2) This gene encodes a mammalian peptidase that, at neutral pH, removes tripeptides from the N terminus of longer peptides. The protein has a specialized function that is essential for some MHC class I antigen presentation. The protein is a high molecular mass serine exopeptidase; the amino acid sequence surrounding the serine residue at the active site is similar to the peptidases of the subtilisin class rather than the trypsin class. [provided by RefSeq, Jul 2008]
TPP2 Gene-Disease associations (from GenCC):
  • immunodeficiency 78 with autoimmunity and developmental delay
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, max_spliceai. No scorers claiming Uncertain. Scorers claiming Benign: dbscSNV1_RF.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330588.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPP2
NM_001330588.2
MANE Select
c.496-3T>G
splice_region intron
N/ANP_001317517.1Q5VZU9
TPP2
NM_001367947.1
c.496-3T>G
splice_region intron
N/ANP_001354876.1
TPP2
NM_003291.4
c.496-3T>G
splice_region intron
N/ANP_003282.2P29144

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPP2
ENST00000376052.5
TSL:5 MANE Select
c.496-3T>G
splice_region intron
N/AENSP00000365220.3Q5VZU9
TPP2
ENST00000376065.8
TSL:1
c.496-3T>G
splice_region intron
N/AENSP00000365233.4P29144
TPP2
ENST00000912746.1
c.496-3T>G
splice_region intron
N/AENSP00000582805.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
33

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
18
DANN
Benign
0.56
PhyloP100
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.97
dbscSNV1_RF
Benign
0.62
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.44
Position offset: -41
DS_AL_spliceai
0.96
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555298364; hg19: chr13-103271069; API